Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
ABL Inc
ABL Inc
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
CleanLock Module: AES Clean Technology launches new cleanroom airlock
The cleanroom provider has launched its new airlock, which offers a secure transition for people and materials entering and exiting cleanroom environments
New material captures coronavirus particles to boost face mask efficiency
Researchers at the University of Liverpool have looked to significantly boost face mask efficiency by developing a new material that captures coronavirus particles
Cell therapy innovation: Germfree and Orgenesis enter strategic partnership
Germfree and Orgenesis have announced an asset purchase and strategic partnership aimed at advancing Orgenesis’ therapeutic programmes, its suite of product development and...
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Manufacturing
Advanced Biological Laboratories reaches milestone for COVID-19 assay
ABL has received CE-IVD Registration for its UltraGene Combo2Screen SARS-CoV-2 Assay
Containment
ABL acquires former Accinov GMP manufacturing plant
The US biotech CDMO now operates a 6,500sqm facility in Lyon equipped with grade B and C cleanrooms and self-contained labs
Pharmaceutical
ABL Europe chooses Sartorius
Biotech company has signed a supply partnership agreement with Sartorius to increase new viral vector manufacturing capacity at its facility in Strasbourg
Subscribe now